1. Home
  2. TDAY vs SPTX Comparison

TDAY vs SPTX Comparison

Compare TDAY & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TDAY

USA TODAY Co. Inc.

HOLD

Current Price

$6.36

Market Cap

1.1B

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$24.86

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TDAY
SPTX
Founded
2013
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2013
2026

Fundamental Metrics

Financial Performance
Metric
TDAY
SPTX
Price
$6.36
$24.86
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
2.8M
109.3K
Earning Date
04-30-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
105.56
N/A
EPS
0.18
N/A
Revenue
$1,526,024,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$35.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.54
$17.59
52 Week High
$9.21
$28.38

Technical Indicators

Market Signals
Indicator
TDAY
SPTX
Relative Strength Index (RSI) 35.99 51.93
Support Level $5.76 $23.23
Resistance Level $6.65 $28.38
Average True Range (ATR) 0.31 2.15
MACD 0.02 -0.21
Stochastic Oscillator 41.80 16.79

Price Performance

Historical Comparison
TDAY
SPTX

About TDAY USA TODAY Co. Inc.

USA Today Co Inc is a diversified media company with national and local reach, dedicated to empowering and enriching communities. It prioritizes a digital-first approach, focusing on audience growth and engagement while diversifying revenue streams. Through its trusted brands, including the USA TODAY NETWORK, comprised of the national publication, USA TODAY, and local media organizations, including a network of local properties, in the United States, and Newsquest, a wholly-owned subsidiary operating in the United Kingdom, provide essential journalism, local content, and digital experiences to audiences and businesses. Its digital marketing solutions brand, LocaliQ, supports small and medium-sized businesses with digital marketing products and solutions.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: